- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04979754
REnal TRansplant Outcomes After CARdiac Surgery (RETROCAR) (RETROCAR)
December 8, 2021 updated by: Alexandre OUATTARA, University Hospital, Bordeaux
Long-term Renal Outcome After Cardiac Surgery : Impact of Previous Renal Transplantation
In this retrospective study, the authors assess long term renal outcome in renal transplant recipients after cardiac surgery with cardiopulmonary bypass, and research factors associated with poor long term renal outcome.
Study Overview
Status
Completed
Intervention / Treatment
Detailed Description
Post-operative mortality after cardiac surgery is increased in renal transplant recipients, compared with general population of cardiac surgery, or with kidney transplant recipients not undergoing cardiac surgery.
If the survival of this specific population is now well studied, the long-term renal outcome is much less studied.
Previous studies show a trend for increased risk of allograft dysfunction and need for permanent dialysis.
This study proposes to compare long term renal outcome between renal transplant recipients and non-renal transplant recipients.
Study Type
Observational
Enrollment (Actual)
93
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Pessac, France, 33604
- Bordeaux University Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Consecutive renal transplant récipients, apparied in a 1:2 ratio with non renal transplant récipients, undergoing cardiac surgery, and meeting the protocol criteria between january 2010 and december 2019, in university hospital of Bordeaux.
Description
Inclusion Criteria for Renal Transplant Recipients group:
- Previous renal transplantation
- Who underwent cardiac surgery with CPB
Inclusion Criteria for Non Renal Transplant Récipients group:
- No previous renal transplantation
- Who underwent cardiac surgery with CPB
- Apparied with Renal Transplant récipients with the 5 following criteria : age, sex, previous diagnosis of diabete, type of cardiac surgery (isolated coronary artery bypass graft, valvular surgery, aorta surgery, combined surgery), best glomerular filtration rate with CKD-EPI formula at +/- 15 ml/min, in the 3 pre-operative months
Exclusion Criteria:
- Patients requiring mechanical circulatory support (Extracorporeal Membrane Oxygenation)
- Pre-operative permanent dialysis
- Aorta dissection extended to renal arteries
- Non-elective surgery for infective endocarditis
- Previous hepatic, pancreatic or cardiac transplantation
- Death in the 30 first days after cardiac surgery
- Patient not meeting the inclusion criteria
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
RENAL TRANSPLANT RECIPIENTS
All patients with previous renal transplantation undergoing cardiac surgery with cardiopulmonary bypass
|
retrospective study : standard of care
|
|
NON RENAL TRANSPLANT RECIPIENTS
All patients without previous renal transplantation undergoing cardiac surgery with cardiopulmonary bypass
|
retrospective study : standard of care
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Long-term renal outcome
Time Frame: 12 months after surgery
|
Proportion of patients meeting a composite criterion : death or permanent dialysis or doubling the baseline serum creatinine value
|
12 months after surgery
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Glomerular Filtration Rate (GFR)
Time Frame: 30 days after surgery
|
Glomerular Filtration Rate (GFR) calculated with CKD-EPI formula
|
30 days after surgery
|
|
Glomerular Filtration Rate (GFR)
Time Frame: 12 months after surgery
|
Glomerular Filtration Rate (GFR) calculated with CKD-EPI formula
|
12 months after surgery
|
|
Vital status
Time Frame: 12 months after surgery
|
Mortality after surgery
|
12 months after surgery
|
|
Major Adverse Kidney Events
Time Frame: Up to 12 months after surgery
|
Major Adverse Kidney Events defined by new receipt of Renal replacement therapy (RRT), or Acute Kidney Injury (AKI) episodes with persistent renal dysfunction and final serum creatinine value before hospital discharge ≥ 200 % of the baseline serum creatinine
|
Up to 12 months after surgery
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
November 1, 2020
Primary Completion (Actual)
August 31, 2021
Study Completion (Actual)
September 30, 2021
Study Registration Dates
First Submitted
July 5, 2021
First Submitted That Met QC Criteria
July 16, 2021
First Posted (Actual)
July 28, 2021
Study Record Updates
Last Update Posted (Actual)
December 9, 2021
Last Update Submitted That Met QC Criteria
December 8, 2021
Last Verified
December 1, 2021
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- SAR Sud study one
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cardiac Surgery
-
Tribhuvan University Teaching Hospital, Institute...CompletedCardiac Surgery | Cardiac Surgery Requiring Cardiopulmonary BypassNepal
-
University of Sao Paulo General HospitalInstituto Dante Pazzanese de Cardiologia; Irmandade da Santa Casa de Misericordia... and other collaboratorsRecruitingCardiac Surgery | ERAS | Digital Health | Cardiac Surgery-CABGBrazil
-
Nationwide Children's HospitalCompleted
-
Shanghai Zhongshan HospitalRecruitingCardiac Surgery | Cardiac OutputChina
-
Asan Medical CenterCompleted
-
Universitätsklinikum Hamburg-EppendorfCompletedSerratus Anterior Plane Block | Minimal Invasive Cardiac Surgery | Minimal Invasive Cardiac Surgery Mitral Valve SurgeryGermany
-
Sheba Medical CenterTerminatedDisorder; Heart, Functional, Postoperative, Cardiac Surgery | Heart; Dysfunction Postoperative, Cardiac SurgeryIsrael
-
Nantes University HospitalCompletedCardiac Surgery Requiring Cardiopulmonary Bypass | Cardiac Surgery Under Extra Corporeal CirculationFrance
-
McMaster UniversityCanadian Institutes of Health Research (CIHR); Population Health Research Institute and other collaboratorsActive, not recruitingSurgery (Cardiac) | Surgery (Major Vascular)Canada, United Kingdom
-
Baylor Research InstituteChiesi USA, Inc.CompletedSurgery | Cardiac Surgery | Surgery--Complications | Percutaneous Coronary InterventionUnited States
Clinical Trials on standard of care
-
brett rasmussenCompleted
-
Indonesia UniversityCompletedCovid19 | AcupunctureIndonesia
-
Aventusoft, LLC.National Heart, Lung, and Blood Institute (NHLBI); Cleveland Clinic FloridaRecruitingHeart Failure (HF)United States
-
Emory UniversityNational Institute of Mental Health (NIMH)Active, not recruitingHiv | Sexual Behavior | Treatment Adherence | Adolescent Behavior | Reproductive Behavior | AIDS | Treatment ComplianceKenya
-
Vascular Biogenics Ltd. operating as VBL TherapeuticsCompletedSevere COVID-19Israel
-
Ruijin HospitalRecruitingCOVID-19 PneumoniaChina
-
Institut Claudius RegaudCompletedMETASTATIC CANCERFrance
-
Ziv HospitalNot yet recruiting
-
Hofseth Biocare ASAKGK Science Inc.CompletedCovid-19 | COVIDCanada, Brazil, Hungary, Mexico, Serbia
-
City University of New York, School of Public HealthNew York State Psychiatric Institute; University of KwaZulu; International Initiative... and other collaboratorsCompleted